uveitis-for example, cataract, secondary glaucoma, and macular abnormalities, are included in many epidemiological studies about blindness, but how many of these are actually attributable to uveitis is not specified. 7 The largest population based study of the Western world, the Framingham Eye Study, illustrates this phenomenon: patients with blindness due to retinal toxoplasma lesions are classified as having macular degeneration; secondary cataract is indicated but carries no aetiological diagnosisfor example, uveitis, trauma. 7 Proper population based studies on the extent of uveitis as a cause of blindness and visual impairment unfortunately do not exist, although such data would be a very beneficial contribution to our knowledge about uveitis.
Definitions
Blindness and low vision are always measured as the visual acuity of the better eye, since vision in this eye determines the actual maximum binocular visual acuity. Blindness is defined by the World Health Organisation (WHO) as the best possible corrected visual acuity in the better eye of less than 0.05 (20/400) or corresponding visual field loss of <10°. Severe visual impairment is defined as the best possible corrected visual acuity in the better eye of 0.05 (20/400) or more but less than 0.1 (20/200) (see Table 1 ). 8 
'4"
Legal blindness is defined as the level of blindness that makes a person eligible for a reduction in tax and other benefits in certain countries. In the USA and in most Anglo-American countries the threshold for this is 0.1 (20/ 200) The results of these studies on blindness in the Western world are difficult to interpret. Very often the classification of diseases is not consistent: anatomical diagnosis (for example, corneal opacities, cataract) and causal diagnosis (for example, onchocerciasis, trachoma) are used in one and the same system simultaneously. Thus, in most studies one entity may appear in different categories-for exam- Blindness in the Western world In the Western world, blindness is mainly the result of disorders of the posterior segment of the eye as age-related macular degeneration and diabetic retinopathy. Both are associated with older age and account for 12% to 43% and 7% to 17% of all cases of blindness."1-"38 19 As visual impairment due to diabetic retinopathy has become treatable because of increased screening and early treatment, its incidence has decreased relatively compared with agerelated macular degeneration where, essentially, no treatment is available." 12 There are some differences reported about the prevalence of causes of blindness between the European countries and the USA.20 As study designs are often different, the comparison of data is extremely difficult. Of special interest is the higher incidence of blindness among the black population in the USA, probably mainly the result of socioeconomic factors and the high incidence of glaucoma in this population group.21'2' Recently, it has been reported that the prevalence of age-related macular degeneration may be less common in Europe than the USA.24 It has been estimated that uveitis causes 10% of the cases of blindness in the USA, while European studies mention percentages of 3% to 7%.5 18 1925 Blindness in the developing countries Many cases of blindness in the developing countries would essentially be treatable or preventable if the resources and staff were available. Much attention has been paid in ophthalmological discussions to cataracts in developing countries.26 27 But, in addition to surgical problems such as cataracts, one must not forget that many other ocular diseases in developing countries may be prevented (see Table 2 ).28 29 Prevention of these diseases is obviously a major problem, as they still have a high prevalence in developing countries. For example, the leading cause of world childhood blindness is vitamin A deficiency causing xerophthalmia, which accounts for 70% of 500 000 blind children every year. 8 Infectious causes of keratitis and uveitis may be treatable and form a major problem in this part of the world. Trachoma alone accounts for one quarter of all the blind people in the world. This is also the case in onchocerciasis which ranks as the fourth cause ofblindness worldwide and is mainly seen in sub-Saharan Africa.8 Visual loss in onchocerciasis is the consequence of inflammation of both the anterior and posterior segment. Prevention may be possible by the annual administration of ivermectin, and fortunately the number of infected patients is decreasing.28 30 .1 Nevertheless, the number of blind people as a result of onchocerciasis (globally 360 000), one of the uveitis entities, indicates the tremendous portion of blindness caused by intraocular inflammation. 8 An estimated 250 000 people in the world are blind because of the sequelae of leprosy, another infectious Table 3 ). Table 3 )7 [11] [12] [13] Blindness in children in the Western world is mostly seen in conditions that lead to blindness in very early childhood and about half of children are blind as a result of brain disorders. The major ocular causes are retinopathy of prematurity (20%), optic nerve atrophy (20%), congenital malformations, (15%) and tapetoretinal degenerations (10%) (see Table 4 ).4A7 The incidence of several ofthese is decreasing as a result of prevention, early treatment, and prenatal diagnosis.47 Studies on the registration of blind people in a hospital population or blind registration studies have shown that the middle aged group represents about 26% to 32% of all the blind people in a Western population.12192' Only a limited number of studies report data on specific age groups other than the elderly or children. Reported diseases that cause blindness at a younger age than 65 years included accidents, optic nerve atrophy, tapetoretinal degeneration, congenital anomalies, and toxic damage including retinopathy ofprematurity and Table 5 )12 19 25 Economically speaking, the middle aged group (aged 20 to 65 years) is the most important as it includes the working age range. For many causes of blindness in this group no definitive cure is available. As Table 5 indicates, the blindness in adults in middle age that is caused by treatable diseases narrows down essentially to two large entities: diabetic retinopathy and uveitis accounting for about 20% and 10% respectively.5 12 The main cause of blindness in diabetes is not proliferative retinopathy any more but macular oedema occurring in exudative diabetic retinopathy."50 Thus, blindness due to diabetes will probably decrease in the younger age group, while it is expected to increase despite treatment in the older age group because of a proportionally larger increase of patients living longer with diabetes mellitus and a higher incidence of macular oedema.5' 52 As mentioned earlier, only a few studies describe the causes of blindness in the middle aged adult. This is astonishing as it has been reported that 97% of the annual federal budgetary costs of blindness in the USA is spent on blind people in the adult group of working age. 5 Uveitis as a cause ofblindness in the Western world
The sequelae of uveitis that may cause visual impairment are well known and include cataract, glaucoma, band keratopathy, vitreous opacities, retinal scars, retinal detachment, retinal vascular abnormalities, cystoid macular oedema, and optic atrophy. Several of these are surgically treatable, such as cataract and glaucoma.54 There are no studies on the incidence of these vision threatening complications in uveitis, so the impact of therapy and prevention of visual loss in uveitis still remains unclear.
Blindness due to uveitis is usually not reflected in results reported on epidemiology of blindness and only few data are available about its incidence. It is estimated that it causes 10% to 15% of all cases of total blindness in the USA. 56 The percentage of blindness in the Western world that was attributed to uveitis was similar in those studies where uveitis was reported, and varied from 3% to 7% of the total blindness. As these studies do not include all uveitis cases and do not report separately on the complications of uveitis, such as cataract and glaucoma, this percentage is probably higher..8 19 25 The prevalence of uveitis in Western countries has been reported as 38 per 100 000 and the incidence is about 14 to [72] [73] [74] [75] virus retinitis. -Of special interest is blindness in patients with acquired immunodeficiency syndrome (AIDS), which is still increasing and is almost always due to viral uveitis. Cytomegalovirus retinitis will develop in 20% to 34% of patients with AIDS. Untreated, it will lead to blindness within several months.75 Owing to failure of virostatic treatment to control the disease, the retinitis recurs in the majority of patients. As improved therapy leads to longer survival in AIDS patients, it can be expected-that the number of blind AIDS patients will increase.76
Socioeconomic impact ofblindness due to uveitis In the USA the estimated federal budget costs for a blind person in the working age group-excluding costs for medical care, but including all state benefits, etc, amount to $12 000 per person year.5' It is reported that in the USA alone 1.1 million are legally blind, 337 000 of them in the age group between 20 and 65 years. It is estimated that in the USA alone 2.3 million suffer from uveitis and that uveitis causes 10% of the blindness encountered.77 78 
